Table 1.
Characteristics of the cohort of one-year sepsis survivors
Men N = 10 556 | Women N = 7994 | |
---|---|---|
Admission year, N (%) | ||
2005–2008 | 2074 (19.6) | 1557 (19.5) |
2009–2012 | 3721 (35.3) | 2773 (34.7) |
2013–2016 | 4761 (45.1) | 3664 (45.8) |
Age at sepsis diagnosis, median (IQR) | 67 (56–75) | 65 (52–74) |
Charlson comorbidity index, N (%) | ||
0 | 9 021 (85.5) | 7 276 (91.0) |
1–2 | 669 (6.3) | 355 (4.4) |
3 or more | 849 (8) | 344 (4.3) |
Data missing | 17 (0.2) | 19 (0.2) |
AIDS, N (%) | ||
Yes | 11 (0.1) | 6 (0.1) |
No | 8319 (78.8) | 6350 (79.4) |
Data missing | 2226 (21.1) | 1638 (20.5) |
Cirrhosis, N (%) | ||
Yes | 112 (1.1) | 86 (1.1) |
No | 8218 (77.9) | 6270 (78.4) |
Data missing | 2226 (21.1) | 1638 (20.5) |
Admission type | ||
Surgical admission, N (%) | 1523 (14.4) | 1304 (16.3) |
Elective, N (%) | 281 (18.5) | 193 (14.8) |
Emergency, N (%) | 1242 (81.5) | 1111 (85.2) |
Data missing | 53 (0.5) | 19 (0.24) |
Emergency admission, N (%) | ||
Yes | 10,041 (95.5) | 7683 (96.1) |
No | 477 (4.2) | 298 (3.7) |
Data missing | 38 (0.3) | 13 (0.2) |
SAPS 3, median (IQR) | 62 (54–71) | 60 (52–69) |
Vasoactive treatment on admission, No (%) | ||
Yes | 1330 (12.6) | 1030 (12.9) |
No | 7000 (66.3) | 5326 (66.6) |
Data missing | 2223 (21.1) | 1638 (20.5) |
ICU length of stay, N (%) | ||
< 1 d | 4446 (42.1) | 3336 (41.7) |
1–2 d | 2077 (19.7) | 1740 (21.8) |
3–7 d | 1025 (9.7) | 741 (9.3) |
8–14 d | 391 (3.7) | 273 (3.4) |
> 14 d | 391 (3.7) | 266 (3.3) |
Data missing | 2223 (21.1) | 1638 (20.5) |
Cancer diagnosis within 5 years before onset of follow-up*, N (%) | ||
Yes | 2324 (22) | 1384 (17.3) |
No | 8232 (78) | 6610 (82.7) |
Ongoing cancer treatment on admission, N (%) | ||
Yes | 657 (6.2) | 590 (7.4) |
No | 7673 (72.7) | 5766 (72.1) |
Data missing | 2226 (21.1) | 1638 (20.5) |
Characteristics of the cohort of one-year sepsis survivors at the index ICU admission or at the start of follow-up (i.e., one year after the index admission). IQR inter-quartile range, SAPS 3 Simplified Acute Physiology Score 3, AIDS acquired immune deficiency syndrome
*Based on data from Swedish Cancer Registry